‘Sonic hedgehog’ protein could impact Parkinson’s disease dyskinesia


Author: Johanna Stiefler JohnsonPublished: 30 September 2021

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

An abstract image of brain neuron pathways.

Dyskinesia is often caused by extended use of the common Parkinson’s medication levodopa – and can be debilitating for those with the condition. Now, researchers in the US may have found a way to suppress these involuntary movements through a protein called ‘sonic hedgehog’.

To conduct their study, the team administered levodopa and sonic hedgehog agonists to rodent and non-human primate models of the condition. The results revealed that dopamine neurons use the protein to communicate with other neurons thought to play a role in levodopa-induced dyskinesia.

Increased signalling of sonic hedgehog pathways was found to reduce this dyskinesia – providing “novel insight” into its formation and a “potential therapeutic solution”.

“What we find,” wrote corresponding study author Professor Andreas Kottmann, “is that in several animal models, by replacing … dopamine together with agonists that mimic the effects of sonic hedgehog, these dyskinesias can be very much suppressed.”

Read more:

Ca Parkinson’s disease be detected through facial expressions?

Survey highlights seven walking strategies for Parkinson’s disease

Go Back

Share this story


Related articles


3 Parkinson’s disease symptoms you need to know about

Our readers discuss facial masking, sleep disturbance and voice problems


sponsored article


Podcast: Living with ‘advanced’ Parkinson’s disease

From coping with changing symptoms to keeping a positive attitude

Heap of medical pills in white, blue and other colors. Pills in plastic package

PD in Practice

Dopamine agonists for Parkinson’s: a simple introduction

Find out more about Parkinson’s medication